Centogene
Canan Has is currently serving as the Head of Data Insights at CENTOGENE. Previously, Canan has held positions such as Postdoctoral Researcher at Universitätsklinikum Carl Gustav Carus, MPI-CBG, and Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. with a focus on multiomics data integration and biomarker discovery. Canan also co-founded Bionia GmbH, a bioinformatics company in Turkey, and has a background in teaching and developing bioinformatics courses. Canan holds a Ph.D. in Biomathematics, Bioinformatics, and Computational Biology, and is currently pursuing a Bachelor's degree in Sociology.
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.